Evidence map›Paper›PMID 25869807›Full record

ArticleMolecular psychiatry2015

NOMA-GAP/ARHGAP33 regulates synapse development and autistic-like behavior in the mouse.

S Schuster, M Rivalan, U Strauss, L Stoenica, T Trimbuch, N Rademacher, S Parthasarathy, D Lajkó, C Rosenmund, S A Shoichet and 3 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Roles of AMPA receptors in social behaviors.Frontiers in synaptic neuroscience · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

S SchusterDendritic Development, Institute of Cell and Neurobiology, Charité Universitätsmedizin Berlin, Berlin, Germany.
M RivalanInstitute of Cognitive Neurobiology, Humboldt University Berlin and Berlin Mouse Clinic for Neurology and Psychiatry, Charité Universitätsmedizin, Berlin, Germany.
U StraussIonic Current Development, Institute of Cell and Neurobiology, Charité Universitätsmedizin Berlin, Berlin, Germany.
L StoenicaIonic Current Development, Institute of Cell and Neurobiology, Charité Universitätsmedizin Berlin, Berlin, Germany.
T TrimbuchNeuroscience, NeuroCure-NWFZ, Charité Universitätsmedizin Berlin, Berlin, Germany.
N RademacherMolecular Neurobiology and Genetics, NeuroCure-NWFZ, Charité Universitätsmedizin Berlin, Berlin, Germany.
S ParthasarathyCortical Development, Institute of Cell and Neurobiology, Charité Universitätsmedizin Berlin, Berlin, Germany.
D LajkóDendritic Development, Institute of Cell and Neurobiology, Charité Universitätsmedizin Berlin, Berlin, Germany.
C RosenmundNeuroscience, NeuroCure-NWFZ, Charité Universitätsmedizin Berlin, Berlin, Germany.
S A ShoichetMolecular Neurobiology and Genetics, NeuroCure-NWFZ, Charité Universitätsmedizin Berlin, Berlin, Germany.
Y WinterInstitute of Cognitive Neurobiology, Humboldt University Berlin and Berlin Mouse Clinic for Neurology and Psychiatry, Charité Universitätsmedizin, Berlin, Germany.
V TarabykinCortical Development, Institute of Cell and Neurobiology, Charité Universitätsmedizin Berlin, Berlin, Germany.
M RosárioDendritic Development, Institute of Cell and Neurobiology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropsychiatric developmental disorders, such as autism spectrum disorders (ASDs) and schizophrenia, are typically characterized by alterations in social behavior and have been linked to aberrant dendritic spine and synapse development. Here we show, using genetically engineered mice, that the Cdc42 GTPase-activating multiadaptor protein, NOMA-GAP, regulates autism-like social behavior in the mouse, as well as dendritic spine and synapse development. Surprisingly, we were unable to restore spine morphology or autism-associated social behavior in NOMA-GAP-deficient animals by Cre-mediated deletion of Cdc42 alone. Spine morphology can be restored in vivo by re-expression of wild-type NOMA-GAP or a mutant of NOMA-GAP that lacks the RhoGAP domain, suggesting that other signaling functions are involved. Indeed, we show that NOMA-GAP directly interacts with several MAGUK (membrane-associated guanylate kinase) proteins, and that this modulates NOMA-GAP activity toward Cdc42. Moreover, we demonstrate that NOMA-GAP is a major regulator of PSD-95 in the neocortex. Loss of NOMA-GAP leads to strong upregulation of serine 295 phosphorylation of PSD-95 and moreover to its subcellular mislocalization. This is associated with marked loss of surface α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and defective synaptic transmission, thereby providing a molecular basis for autism-like social behavior in the absence of NOMA-GAP.

Indexed as

Social BehaviorAnimalsAutism Spectrum DisorderBehavior, AnimalCells, CulturedDendritic SpinesDisease Models, AnimalFemaleGTPase-Activating ProteinsGuanylate KinasesHippocampusMaleMiceMice, Inbred C57BLMice, TransgenicNeocortexGTPase-Activating ProteinsGuanylate KinasesReceptors, AMPArho GTPase-activating proteinTCGAP protein, mouse

Identifiers

PMID25869807
OpenAlexW2032466273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.